Related Experiment Video

Updated: Dec 21, 2025

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

15.8K

A Post-COVID-19 Parkinsonism in the Future?

Aliaksandr V Boika1

  • 1Department of Neurology and Neurosurgery, Belarusian Medical Academy of Post-Graduate Education, Minsk, Belarus.

Movement Disorders : Official Journal of the Movement Disorder Society
|May 13, 2020
PubMed
Summary

No abstract available in PubMed .

More Related Videos

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
11:12

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation

Published on: July 16, 2014

22.9K
Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
07:26

Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking

Published on: September 26, 2019

8.1K

Related Experiment Videos

Last Updated: Dec 21, 2025

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
10:28

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

15.8K
Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
11:12

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation

Published on: July 16, 2014

22.9K
Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking
07:26

Characterizing the Relationship Between Eye Movement Parameters and Cognitive Functions in Non-demented Parkinson's Disease Patients with Eye Tracking

Published on: September 26, 2019

8.1K

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

1.5K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.5K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

852
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
852
Neural Regulation01:37

Neural Regulation

42.9K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
42.9K

Articles linked to this work by shared authors, journal, and citation graph.

Post-COVID worsening of a Parkinson's disease patient.

Clinical case reports·2021

Joint Risk Factor Combinations with Additive Interaction Increase the Risk of Parkinson's Disease.

Movement disorders : official journal of the Movement Disorder Society·2026

COVID-19 Amplifies Sex-Specific Dopamine and Glial Responses in a Parkinson's Disease Mouse Model.

Movement disorders : official journal of the Movement Disorder Society·2026

Early Longitudinal Brain Network Changes in Huntington's Disease Before Clinical Motor Onset.

Movement disorders : official journal of the Movement Disorder Society·2026

Expanded ATXN3 CAG Repeat is Stable in Human Purkinje Cells.

Movement disorders : official journal of the Movement Disorder Society·2026

Cannabis-Based Oil for Pain and Other Non-Motor Symptoms in Parkinson's Disease: A Randomized Controlled Trial.

Movement disorders : official journal of the Movement Disorder Society·2026

Rare Heterozygous Loss-of-Function Variants in MCOLN1 Identified in Two Sporadic Patients with α-Synucleinopathies.

Movement disorders : official journal of the Movement Disorder Society·2026

Somalia's lifeline: Digitalization and AI.

Human vaccines & immunotherapeutics·2026

Trends and disparities in acute respiratory distress syndrome-related mortality in the United States, 1999-2020: a CDC WONDER database analysis.

Annals of medicine and surgery (2012)·2026

Socioeconomic Factors and Prevalence of Functional Dependence Assessed by the Barthel Index and the Lawton-Brody Scale in the Older Population Residing in Block Hazratbal, Srinagar, India.

Cureus·2026

Nationwide estimates of all-cause and cause-specific mortality among individuals with gender dysphoria in Sweden, 2001-2023: a register-based cohort study.

EClinicalMedicine·2026

PRKCD Orchestrates Sevoflurane-Induced Cognitive Dysfunction in Aged Rats by Regulating PINK1/PRKN Mitophagy Pathway.

Journal of cellular and molecular medicine·2026

Brief Report on Sociodemographic Patterns of Lung Cancer in Individuals Who Never Smoked.

Clinical lung cancer·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us